Pharmacokinetic and safety of serelaxin when added to standard of care in pediatric patients hospitalized with acute heart failure

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-002847-28

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- evaluate the safety and tolerability of an iv serelaxin infusion in addition to standard of care in hospitalized pediatric patients with AHF. - investigate the effects of age on the pharmacokinetics of serelaxin given as iv infusion in addition to standard of care in hospitalized pediatric patients with AHF


Critère d'inclusion

  • Acute heart failure

Liens